Company: INMB
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001213900-25-104141
Chunk: 104

Company: Inmune Bio, Inc.
Filing Date: 2025-10-30
Form: 10-Q
Item: Part I, Item 3
Chunk 104
---
 inmb:EachPhaseInitiationMember
      inmb:PITTAgreementMember

    2025-01-01
    2025-09-30

    0001711754
    
      inmb:EachPhaseIIIInitiationMember
      inmb:PITTAgreementMember

    2025-01-01
    2025-09-30

    0001711754
    
      us-gaap:TechnologyBasedIntangibleAssetsMember
      inmb:PITTAgreementMember

    2025-01-01
    2025-09-30

    0001711754
    
      us-gaap:USTreasuryBillSecuritiesMember
      us-gaap:FairValueMeasurementsRecurringMember

    2025-09-30

    0001711754
    
      us-gaap:USTreasuryBillSecuritiesMember
      us-gaap:FairValueInputsLevel1Member
      us-gaap:FairValueMeasurementsRecurringMember

    2025-09-30

    0001711754
    
      us-gaap:USTreasuryBillSecuritiesMember
      us-gaap:FairValueInputsLevel2Member
      us-gaap:FairValueMeasurementsRecurringMember

    2025-09-30

    0001711754
    
      us-gaap:USTreasuryBillSecuritiesMember
      us-gaap:FairValueInputsLevel3Member
      us-gaap:FairValueMeasurementsRecurringMember

    2025-09-30

    0001711754
    
      us-gaap:MoneyMarketFundsMember
      us-gaap:FairValueMeasurementsRecurringMember

    2025-09-30

    0001711754
    
      us-gaap:MoneyMarketFundsMember
      us-gaap:FairValueInputsLevel1Member
      us-gaap:FairValueMeasurementsRecurringMember

    2025-09-30

    0001711754
    
      us-gaap:MoneyMarketFundsMember
      us-gaap:FairValueInputsLevel2Member
      us-gaap:FairValueMeasurementsRecurringMember

    2025-09-30

    0001711754
    
      us-gaap:MoneyMarketFunds